Dissociation-enhanced lanthanide fluorescence immunoassay of lipoprotein(a) in serum

25Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Lipoprotein(a), a human serum lipoprotein structurally related to low-density lipoprotein (LDL), contains in addition to apolipoprotein B (apo B) apolipoprotein(a) [apo(a)], a glycoprotein with a strong homology to plasminogen. Lp(a) is a risk factor for coronary heart disease and ischemic cerebrovascular disease. Several immunological techniques are used to quantify Lp(a) in human serum, including radioimmunoassays, rocket immunoelectrophoresis, and enzyme-linked immunosorbent assays. Only the last method is suitable for large-scale clinical studies. We describe another solid-phase immunoassay, based on the dissociation-enhanced lanthanide fluorescence system Delfia® (Wallac Oy), and outline the technical details. A polyclonal antiserum directed against Lp(a) was used as the capture antibody. Two kinds of detection antibodies were applied, a polyclonal antiserum against apo B and the polyclonal antiserum against Lp(a). The results agree excellently with the values estimated by rocket immunoelectrophoresis. This assay is easily established, measures Lp(a) in a wide concentration range, and is suitable for screening large populations.

Author supplied keywords

Cite

CITATION STYLE

APA

Jürgens, G., Hermann, A., Aktuna, D., & Petek, W. (1992). Dissociation-enhanced lanthanide fluorescence immunoassay of lipoprotein(a) in serum. Clinical Chemistry, 38(6), 853–859. https://doi.org/10.1093/clinchem/38.6.853

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free